AU2021901102A0 - Dual mode dispenser and method of use - Google Patents

Dual mode dispenser and method of use

Info

Publication number
AU2021901102A0
AU2021901102A0 AU2021901102A AU2021901102A AU2021901102A0 AU 2021901102 A0 AU2021901102 A0 AU 2021901102A0 AU 2021901102 A AU2021901102 A AU 2021901102A AU 2021901102 A AU2021901102 A AU 2021901102A AU 2021901102 A0 AU2021901102 A0 AU 2021901102A0
Authority
AU
Australia
Prior art keywords
dual mode
mode dispenser
dispenser
dual
mode
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2021901102A
Inventor
Velimir PAJIC
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liquim Pty Ltd
Original Assignee
Liquim Pty Ltd
Filing date
Publication date
Application filed by Liquim Pty Ltd filed Critical Liquim Pty Ltd
Publication of AU2021901102A0 publication Critical patent/AU2021901102A0/en
Withdrawn legal-status Critical Current

Links

AU2021901102A 2021-04-14 Dual mode dispenser and method of use Withdrawn AU2021901102A0 (en)

Publications (1)

Publication Number Publication Date
AU2021901102A0 true AU2021901102A0 (en) 2021-05-06

Family

ID=

Similar Documents

Publication Publication Date Title
EP3962479A4 (en) Kcnt1 inhibitors and methods of use
EP4143196A4 (en) PI3K-a INHIBITORS AND METHODS OF USE THEREOF
EP3962481A4 (en) Kcnt1 inhibitors and methods of use
EP3972991A4 (en) Nr4a super-repressors and methods of use thereof
EP3969439A4 (en) Acss2 inhibitors and methods of use thereof
EP3986894A4 (en) Ectonucleotidase inhibitors and methods of use thereof
EP4059926A4 (en) Crystal form of tafamidis and preparation method therefor and use thereof
EP4125831A4 (en) Kcnt1 inhibitors and methods of use
EP3952721A4 (en) Endoscope and method of use
EP4058015A4 (en) Allosteric egfr inhibitors and methods of use thereof
EP4031064A4 (en) Oral hygiene system and method of use
EP4005561A4 (en) Nano-micelle preparation of icaritin and preparation method therefor and application thereof
EP3969460A4 (en) Ascaroside derivatives and methods of use
EP3959197A4 (en) Papd5 inhibitors and methods of use thereof
EP4038139A4 (en) Adhesive and methods of use
EP3938119A4 (en) Sealant dispenser and methods of operation
EP3950961A4 (en) Application of kdm5a gene and atrx gene
AU2021901102A0 (en) Dual mode dispenser and method of use
AU2022901005A0 (en) Dual mode dispenser and method of use
EP4110317A4 (en) Kcnt1 inhibitors and methods of use
EP4115902A4 (en) Combined use of ctb006 and ponatinib
EP4146650A4 (en) Beta-lactamase inhibitors and their preparation
EP4127136A4 (en) Use of exosome-based delivery of nf-kb inhibitors
EP4034099A4 (en) Pimobendan formulation and method of use thereof
EP3939978A4 (en) Crystal form of phosphodiesterase inhibitor, preparation method therefor and use thereof